Kupffer Biotherapeutics

Burlingame, United States Founded: 2019 • Age: 7 yrs
Develops innovative technologies for anticancer therapies targeting gastrointestinal cancers.

About Kupffer Biotherapeutics

Kupffer Biotherapeutics was a Healthcare company based in Burlingame (United States) founded in 2019. It develops innovative technologies for anticancer therapies targeting gastrointestinal cancers. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Oncology and Anticancer Therapy. Its competitors include Ironwood Pharma, Ardelyx and Alcresta; 3 of its 3 listed competitors have raised funding.

Company details

Kupffer Biotherapeutics, based in Burlingame, focuses on providing healthcare solutions, advancing biotech innovations, oncology, and anticancer therapy. Develops innovative technologies for anticancer therapies targeting gastrointestinal cancers. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Burlingame, United States
  • Sectors
    Healthcare
  • Website kupfferbio.com

Competitors of Kupffer Biotherapeutics

Kupffer Biotherapeutics has 3 listed competitors in our database, 3 of them funded. They include Ironwood Pharma, Ardelyx and Alcresta.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ironwoodpharma.com1998Cambridge, United States$206.25M220
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
ardelyx.com2007Fremont, United States$61.1M37
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
alcresta.com2011Newton, United States$95.89M52
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
Premium access

Detailed competitors of Kupffer Biotherapeutics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Immunology & Cancer Therapeutics

3 companies that operate in the same segment as Kupffer Biotherapeutics (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Targeted and immune-oncology drugs for cancer treatment are developed.
2010Cambridge, Massachusetts, United StatesUSD 172 M
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
2013San Francisco, California, United StatesUSD 214.78 MUSD 21.05 M211
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Kupffer Biotherapeutics

Kupffer Biotherapeutics was founded in 2019.

Kupffer Biotherapeutics is headquartered in Burlingame, United States. It is registered at Burlingame, California, United States.

Kupffer Biotherapeutics, based in Burlingame, focuses on providing healthcare solutions, advancing biotech innovations, oncology, and anticancer therapy. Develops innovative technologies for anticancer therapies targeting gastrointestinal cancers. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.

Kupffer Biotherapeutics's top competitors include Ironwood Pharma, Ardelyx and Alcresta.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available